State of art and limitations in genetic engineering to induce stable chondrogenic phenotype

Valeria Graceffa, Claire Vinatier, Jerome Guicheux, Christopher H Evans, Martin Stoddart, Mauro Alini, Dimitrios I. Zeugolis

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Current protocols for chondrocyte expansion and chondrogenic differentiation of stem cells fail to reduce phenotypic loss and to mitigate hypertrophic tendency. To this end, cell genetic manipulation is gaining pace as a means of generating cells with stable chondrocyte phenotype. Herein, we provide an overview of candidate genes that either induce cartilage regeneration or inhibit cartilage degeneration. We further discuss in vitro, ex vivo and in vivo viral transduction and non-viral transfection strategies for targeted cells (chondrocytes, mesenchymal stem cells, induced pluripotent stem cells and synovial cells), along with the most representative results obtained in pre-clinical models and in clinical trials. We highlight current challenges and associated risks that slowdown clinical acceptance and commercialisation of gene transfer technologies.

Original languageEnglish (US)
JournalBiotechnology Advances
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Genetic engineering
Genetic Engineering
Stem cells
Chondrocytes
Cartilage
Phenotype
Gene transfer
Technology Transfer
Induced Pluripotent Stem Cells
Genes
Mesenchymal Stromal Cells
Transfection
Regeneration
Stem Cells
Clinical Trials

Keywords

  • Cartilage tissue engineering
  • Gene engineering
  • Genetically engineered cells
  • Non-viral transfection systems
  • Viral transduction systems

ASJC Scopus subject areas

  • Biotechnology

Cite this

State of art and limitations in genetic engineering to induce stable chondrogenic phenotype. / Graceffa, Valeria; Vinatier, Claire; Guicheux, Jerome; Evans, Christopher H; Stoddart, Martin; Alini, Mauro; Zeugolis, Dimitrios I.

In: Biotechnology Advances, 01.01.2018.

Research output: Contribution to journalArticle

Graceffa, Valeria ; Vinatier, Claire ; Guicheux, Jerome ; Evans, Christopher H ; Stoddart, Martin ; Alini, Mauro ; Zeugolis, Dimitrios I. / State of art and limitations in genetic engineering to induce stable chondrogenic phenotype. In: Biotechnology Advances. 2018.
@article{d354be62ef0b4d6db0b346eb256582e9,
title = "State of art and limitations in genetic engineering to induce stable chondrogenic phenotype",
abstract = "Current protocols for chondrocyte expansion and chondrogenic differentiation of stem cells fail to reduce phenotypic loss and to mitigate hypertrophic tendency. To this end, cell genetic manipulation is gaining pace as a means of generating cells with stable chondrocyte phenotype. Herein, we provide an overview of candidate genes that either induce cartilage regeneration or inhibit cartilage degeneration. We further discuss in vitro, ex vivo and in vivo viral transduction and non-viral transfection strategies for targeted cells (chondrocytes, mesenchymal stem cells, induced pluripotent stem cells and synovial cells), along with the most representative results obtained in pre-clinical models and in clinical trials. We highlight current challenges and associated risks that slowdown clinical acceptance and commercialisation of gene transfer technologies.",
keywords = "Cartilage tissue engineering, Gene engineering, Genetically engineered cells, Non-viral transfection systems, Viral transduction systems",
author = "Valeria Graceffa and Claire Vinatier and Jerome Guicheux and Evans, {Christopher H} and Martin Stoddart and Mauro Alini and Zeugolis, {Dimitrios I.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.biotechadv.2018.07.004",
language = "English (US)",
journal = "Biotechnology Advances",
issn = "0734-9750",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - State of art and limitations in genetic engineering to induce stable chondrogenic phenotype

AU - Graceffa, Valeria

AU - Vinatier, Claire

AU - Guicheux, Jerome

AU - Evans, Christopher H

AU - Stoddart, Martin

AU - Alini, Mauro

AU - Zeugolis, Dimitrios I.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Current protocols for chondrocyte expansion and chondrogenic differentiation of stem cells fail to reduce phenotypic loss and to mitigate hypertrophic tendency. To this end, cell genetic manipulation is gaining pace as a means of generating cells with stable chondrocyte phenotype. Herein, we provide an overview of candidate genes that either induce cartilage regeneration or inhibit cartilage degeneration. We further discuss in vitro, ex vivo and in vivo viral transduction and non-viral transfection strategies for targeted cells (chondrocytes, mesenchymal stem cells, induced pluripotent stem cells and synovial cells), along with the most representative results obtained in pre-clinical models and in clinical trials. We highlight current challenges and associated risks that slowdown clinical acceptance and commercialisation of gene transfer technologies.

AB - Current protocols for chondrocyte expansion and chondrogenic differentiation of stem cells fail to reduce phenotypic loss and to mitigate hypertrophic tendency. To this end, cell genetic manipulation is gaining pace as a means of generating cells with stable chondrocyte phenotype. Herein, we provide an overview of candidate genes that either induce cartilage regeneration or inhibit cartilage degeneration. We further discuss in vitro, ex vivo and in vivo viral transduction and non-viral transfection strategies for targeted cells (chondrocytes, mesenchymal stem cells, induced pluripotent stem cells and synovial cells), along with the most representative results obtained in pre-clinical models and in clinical trials. We highlight current challenges and associated risks that slowdown clinical acceptance and commercialisation of gene transfer technologies.

KW - Cartilage tissue engineering

KW - Gene engineering

KW - Genetically engineered cells

KW - Non-viral transfection systems

KW - Viral transduction systems

UR - http://www.scopus.com/inward/record.url?scp=85050091939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050091939&partnerID=8YFLogxK

U2 - 10.1016/j.biotechadv.2018.07.004

DO - 10.1016/j.biotechadv.2018.07.004

M3 - Article

JO - Biotechnology Advances

JF - Biotechnology Advances

SN - 0734-9750

ER -